1.0(top 50%)
2-year impact
1.2(top 50%)
3-year impact
1.2(top 50%)
5-year impact
0.8(top 50%)
10-year impact
49.4K(top 0.1%)
papers
879.6K(top 1%)
citations
243(top 1%)
h-index
1.2(top 50%)
extended IF
57.5K
all documents
886.2K
doc citations
353(top 1%)
g-index

Top Articles

#TitleJournalYearCitations
1CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation19743,202
2HETEROTOPIC TRANSPLANTS OF BONE MARROWTransplantation19681,488
3Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantationTransplantation20031,231
4MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation19951,219
5STROMAL CELLS RESPONSIBLE FOR TRANSFERRING THE MICROENVIRONMENT OF THE HEMOPOIETIC TISSUESTransplantation19741,178
6PRINCIPLES OF SOLID-ORGAN PRESERVATION BY COLD STORAGETransplantation19881,133
7A COMPARISON OF TACROLIMUS (FK506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION AFTER CADAVERIC RENAL TRANSPLANTATION1Transplantation1997991
8SEROTYPING FOR HOMOTRANSPLANTATION XVIII. REFINEMENT OF MICRODROPLET LYMPHOCYTE CYTOTOXICITY TESTTransplantation1968986
9Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host DiseaseTransplantation2006938
10RISK FACTORS FOR PRIMARY DYSFUNCTION AFTER LIVER TRANSPLANTATION—A MULTIVARIATE ANALYSISTransplantation1993901
11International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ TransplantationTransplantation2010853
12DELAYED GRAFT FUNCTION: RISK FACTORS AND IMPLICATIONS FOR RENAL ALLOGRAFT SURVIVAL1Transplantation1997845
13IMPACT OF GRAFT SIZE MISMATCHING ON GRAFT PROGNOSIS IN LIVER TRANSPLANTATION FROM LIVING DONORS1,2Transplantation1999826
14A Comprehensive Risk Quantification Score for Deceased Donor Kidneys: The Kidney Donor Risk IndexTransplantation2009825
15Polyomavirus-Associated Nephropathy in Renal Transplantation: Interdisciplinary Analyses and RecommendationsTransplantation2005799
16VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATIONTransplantation1987776
17SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATIONTransplantation1999759
18PRIMARILY VASCULARIZED ALLOGRAFTS OF HEARTS IN MICETransplantation1973729
19NEUTROPHIL INFILTRATION AS AN IMPORTANT FACTOR IN LIVER ISCHEMIA AND REPERFUSION INJURYTransplantation1993719
20PRESERVATION AND REPERFUSION INJURIES IN LIVER ALLOGRAFTSTransplantation1992714
21THE ROLE OF ENDOTHELIAL CELLS IN INFLAMMATIONTransplantation1990666
22Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in TransplantationTransplantation2013665
23Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors1Transplantation2002664
24Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomesTransplantation2002652
25Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ TransplantationTransplantation2013639
26MULTICENTER RANDOMIZED TRIAL COMPARING TACROLIMUS (FK506) AND CYCLOSPORINE IN THE PREVENTION OF RENAL ALLOGRAFT REJECTION1Transplantation1997614
27EVALUATION OF THE TRYPAN BLUE TECHNIQUE FOR DETERMINATION OF CELL VIABILITYTransplantation1964611
28AN EXTENSION OF THE51Cr-RELEASE ASSAY FOR THE ESTIMATION OF MOUSE CYTOTOXINSTransplantation1968607
29LRISK FACTORS FOR CHRONIC REJECTION IN RENAL ALLOGRAFT RECIPIENTSTransplantation1993606
30INCIDENCE OF SKIN CANCER AFTER RENAL TRANSPLANTATION IN THE NETHERLANDSTransplantation1990577
31PORTAL VEIN THROMBOSIS IN ADULTS UNDERGOING LIVER TRANSPLANTATIONTransplantation2000571
32GENOTYPIC VARIATION IN THE TRANSFORMING GROWTH FACTOR-??1 GENETransplantation1998567
33ORTHOTOPIC LIVER TRANSPLANTATION IN THE RATTransplantation1979544
34A WORLDWIDE, PHASE III, RANDOMIZED, CONTROLLED, SAFETY AND EFFICACY STUDY OF A SIROLIMUS/CYCLOSPORINE REGIMEN FOR PREVENTION OF ACUTE REJECTION IN RECIPIENTS OF PRIMARY MISMATCHED RENAL ALLOGRAFTSTransplantation2001541
35Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cellsTransplantation2003539
36PRODUCTION OF EMBRYONAL α-GLOBULIN BY TRANSPLANTABLE MOUSE HEPATOMASTransplantation1963537
37A RANDOMIZED ACTIVE-CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL IN HEART TRANSPLANT RECIPIENTS1Transplantation1998522
38NEW-ONSET DIABETES AFTER TRANSPLANTATION: 2003 INTERNATIONAL CONSENSUS GUIDELINES1Transplantation2003518
39Maintenance Immunosuppression with Target-of-Rapamycin Inhibitors is Associated with a Reduced Incidence of De Novo MalignanciesTransplantation2005513
40PLASMAPHERESIS AND INTRAVENOUS IMMUNE GLOBULIN PROVIDES EFFECTIVE RESCUE THERAPY FOR REFRACTORY HUMORAL REJECTION AND ALLOWS KIDNEYS TO BE SUCCESSFULLY TRANSPLANTED INTO CROSS-MATCH-POSITIVE RECIPIENTSTransplantation2000509
41RECOMBINANT-INBRED STRAINS AN AID TO FINDING IDENTITY, LINKAGE, AND FUNCTION OF HISTOCOMPATIBILITY AND OTHER GENESTransplantation1971508
42MYCOPHENOLATE MOFETIL IN RENAL ALLOGRAFT RECIPIENTSTransplantation1997506
43Functional bioengineered corneal epithelial sheet grafts from corneal stem cells expanded ex vivo on a temperature-responsive cell culture surfaceTransplantation2004503
44Mixed Allogeneic Chimerism And Renal Allograft Tolerance In Cynomolgus MonkeysTransplantation1995498
45Treatment of Knee Osteoarthritis With Allogeneic Bone Marrow Mesenchymal Stem CellsTransplantation2015491
46Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT TrialTransplantation2009487
47AN IMPROVED METHOD FOR ISOLATION OF MOUSE PANCREATIC ISLETSTransplantation1985480
48SIROLIMUS IN ASSOCIATION WITH MYCOPHENOLATE MOFETIL INDUCTION FOR THE PREVENTION OF ACUTE GRAFT REJECTION IN RENAL ALLOGRAFT RECIPIENTS12Transplantation2000476
49Rates and Risk Factors for Nonadherence to the Medical Regimen After Adult Solid Organ TransplantationTransplantation2007475
50Malignancy after TransplantationTransplantation2005469